financetom
Business
financetom
/
Business
/
Barnwell Industries, Inc. Announces Appointment of Sean Wallace to Expand Strategic M&A Capabilities and Capital Markets Expertise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Barnwell Industries, Inc. Announces Appointment of Sean Wallace to Expand Strategic M&A Capabilities and Capital Markets Expertise
Mar 11, 2026 4:03 AM

HOUSTON, TX / ACCESS Newswire / March 11, 2026 / Barnwell Industries, Inc. ( BRN ) ("Barnwell" or the "Company") today announced the appointment of Sean Wallace as a strategic advisor to enhance the Company's capabilities in mergers and acquisitions and broader corporate development initiatives. Mr. Wallace participated in Barnwell's November 2025 Private Placement.

Mr. Wallace brings more than 30 years of senior financial and corporate leadership experience, including extensive work in capital markets, strategic finance, and M&A. He has served in a series of high-impact executive roles across public and private companies, most recently as Chief Financial Officer and Executive Vice President at AST SpaceMobile, Inc. Prior to that, Mr. Wallace served as Chief Financial Officer, Treasurer, and Vice President at Cogent Communications, a global Tier 1 internet service provider. As CFO, he led capital raising, strategic evaluation, and financial planning efforts. Earlier in his career, he held senior roles at Standard Chartered Bank and co-headed Investment Banking at JPMorgan in the Asia Pacific region. Mr. Wallace is a graduate of Harvard College and Harvard Business School.

"We are thrilled to welcome Sean to Barnwell," said Philip Patman, Jr., Chief Financial Officer and Director of Barnwell Industries ( BRN ). "His proven track record in strategic finance and M&A brings an invaluable perspective as we pursue disciplined growth and value creation."

In his advisory role, Mr. Wallace will work with Barnwell's leadership team to assess and execute strategic opportunities, including potential mergers, acquisitions, divestitures, and other corporate development initiatives that align with the Company's long-term objectives.

"I am excited to be a part of the Barnwell opportunity. Barnwell's unique structure and shareholder base positions the company to identify and attract exciting growth companies, including those in Space, Telecommunications, Emerging Defense, Rare Earths, Reshoring and Energy. I look forward to working with the team to advance the portfolio of Barnwell," Wallace stated.

About Barnwell Industries, Inc. ( BRN )

Barnwell Industries, Inc. ( BRN ) is a diversified company with operations and interests in energy and related assets. The Company is focused on disciplined capital allocation, operational excellence, and high-return growth opportunities.

Forward-Looking Statements

The information contained in this press release contains "forward-looking statements," within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. A forward-looking statement is one which is based on current expectations of future events or conditions and does not relate to historical or current facts. These statements include various estimates, forecasts, projections of Barnwell's future performance, statements of Barnwell's plans and objectives, and other similar statements. Forward-looking statements include phrases such as "expects," "anticipates," "intends," "plans," "believes," "predicts," "estimates," "assumes," "projects," "may," "will," "will be," "should," or similar expressions. Although Barnwell believes that its current expectations are based on reasonable assumptions, it cannot assure that the expectations contained in such forward-looking statements will be achieved. Forward-looking statements involve risks, uncertainties and assumptions which could cause actual results to differ materially from those contained in such statements. The risks, uncertainties and other factors that might cause actual results to differ materially from Barnwell's expectations are set forth in the "Forward-Looking Statements," "Risk Factors" and other sections of Barnwell's annual report on Form 10-K for the last fiscal year and Barnwell's other filings with the Securities and Exchange Commission. Investors should not place undue reliance on the forward-looking statements contained in this press release, as they speak only as of the date of this press release, and Barnwell expressly disclaims any obligation or undertaking to publicly release any updates or revisions to any forward-looking statements contained herein.

COMPANY:

Philip F. Patman, Jr.

Chief Financial Officer and Treasurer

Barnwell Industries, Inc. ( BRN )

24 Greenway Plaza, Suite 1800Q

Houston, Texas 77046

Telephone: +1 (713) 730 7026

Website: www.brninc.com

CONTACT: Barnwell Industries, Inc. ( BRN )

View the original press release on ACCESS Newswire

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Gms Insider Sold Shares Worth $611,436, According to a Recent SEC Filing
Gms Insider Sold Shares Worth $611,436, According to a Recent SEC Filing
Mar 22, 2024
04:06 PM EDT, 03/22/2024 (MT Newswires) -- John C Turner Jr, Director, President and CEO, on March 21, 2024, sold 6,266 shares in Gms (GMS) for $611,436. Following the Form 4 filing with the SEC, Turner has control over a total of 48,074 shares of the company, with 48,074 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1600438/000162828024012722/xslF345X03/wk-form4_1711137754.xml Price: 96.61, Change: +0.01, Percent...
Invivyd's Covid Treatment for Immunodeficiency Disorders Gets FDA Nod; Shares Up Before Trading Halt
Invivyd's Covid Treatment for Immunodeficiency Disorders Gets FDA Nod; Shares Up Before Trading Halt
Mar 22, 2024
03:57 PM EDT, 03/22/2024 (MT Newswires) -- Invivyd ( IVVD ) stock was up 4.5% Friday before its trading was halted to announce an emergency use authorization for its Pemgarda monoclonal antibody to prevent COVID-19 in adults and youths with moderate-to-severe immunodeficiency disorders. The US Food and Drug Administration decision makes Pemgarda available to people 12 years or older with...
Esperion Therapeutics Shares Rise After US FDA Expands Labels for Nexletol, Nexlizet
Esperion Therapeutics Shares Rise After US FDA Expands Labels for Nexletol, Nexlizet
Mar 22, 2024
04:06 PM EDT, 03/22/2024 (MT Newswires) -- Esperion Therapeutics ( ESPR ) shares closed up 8.5% in Friday trading after the company said the US Food and Drug Administration approved Nexletol and Nexlizet for expanded use in cardiovascular risk reduction and lowering low-density lipoprotein cholesterol for both primary and secondary prevention patients. The label expansion covers the use of drugs...
UnitedHealth's Change to start processing $14 billion in medical claims as services come online
UnitedHealth's Change to start processing $14 billion in medical claims as services come online
Mar 22, 2024
(Reuters) -UnitedHealth Group ( UNH ) said on Friday it expects more than $14 billion in medical claims to start flowing soon through its unit Change Healthcare as several services for handling them gradually come online over the next few weeks following a hack last month. The health insurer said its software for preparing medical claims Assurance went online on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved